NASDAQ
NEOG
Last Price
US $13.72
KEY FIGURES
MKT CAP
$3.0B
EPS
TTM$-0.04
EPS Growth (1Y)
-99.20%
PEG
TTMN/M
P/E
TTMN/M
P/S
TTM3.43x
YIELD
—
Profit margin
Current Ratio
Capital Returns
-41.88%
Return on equity
ROIC: -33.20%
Valuation History
-
Price to Earnings
EV/EBITDA: -
Cash flow
Profit margin
GROWTH (5Y CAGR)
Revenue
13.19%
EBITDA
12.10%
Cash flow
-10.12%
Base Cash Flow Valuation (DCF)
Fair Value
Market $13.72
—
Default assumptions
Base EBITDA Valuation
Fair Value
Market $13.72
-80.32%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Cash flow to debt coverage
Neogen Corporation cash flow to debt ratio of 10.48% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Neogen Corporation's free cash flow has increased 168.82% from $-46.35M last year to $31.90M, signaling increasing performance
Debt-to-equity ratio
Neogen Corporation's debt to equity ratio is 0.38, which means that the company's assets are healthy financed, signaling financial stability.
Debt-to-equity trend
Neogen Corporation's debt has decreased relative to shareholder equity from 0.44 last year to 0.38 today, signaling strengthened financials
Net debt to EBITDA
Neogen Corporation has a net debt to EBITDA ratio of 3.57x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
Neogen Corporation's interest coverage ratio is -0.37, which means that the company struggles to meet interest obligations, signaling financial risk.
Profit margin growth
Neogen Corporation's profit margin was -122.06% last year and is -0.91% this year, signaling increasing performance
Current ratio
Neogen Corporation's short-term assets of $604.60M exceed its short-term liabilities of $158.20M
Return on assets
Neogen Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Neogen Corporation's return on equity of -0.37%, is lower than 15.00%, indicating bad performance
Earnings quality
Neogen Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Neogen Corporation had positive net income in only 1 out of 5 years, indicating unstable earnings
Positive free cash flow
Neogen Corporation has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Neogen Corporation has a free cash flow yield of 1.06%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
Neogen Corporation's yearly earnings has increased 99.28% since last year from $-1.09B to $-7.90M, signaling increasing performance
Revenue growth
Neogen Corporation's yearly revenue has decreased 2.71% since last year from $894.66M to $870.40M, signaling decreasing performance
Return on invested capital
ROIC -0.60% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Neogen Corporation's 3-year revenue CAGR of 1.91% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Neogen Corporation had revenue growth in 3 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Neogen Corporation had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity
Base Cash Flow Valuation (DCF)
Neogen Corporation has insufficient data to evaluate this check.
Earnings yield (TTM)
Neogen Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Base EBITDA Valuation
Neogen Corporation is overvalued relative to its fair value price of 2.70 based on Base EBITDA Valuation model
EV/EBITDA (FY)
Neogen Corporation has an EV/EBITDA ratio of 21.17x, which exceeds the 20.00x threshold, indicating the stock may be overvalued relative to its operating earnings
PEG ratio (TTM/FY)
Neogen Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Price-to-book ratio (FY)
Neogen Corporation has a price-to-book ratio of 1.43x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Neogen Corporation has a price-to-sales ratio of 3.44x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue